Q1 2025 Earnings Call Transcript April 29, 2025 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...

The webcast of the presentation will be accessible in the Investor section of the Actuate website. The Actuate management ...

BLACKSBURG, Va. (WDBJ) - Earlier this year, the Food and Drug Administration (FDA) banned the use of Red No.3 dye. This is ...

Xanamem is an investigational product and is not approved for use outside of a clinical trial by the FDA or by any global regulatory authority. Xanamem ® is a trademark of Actinogen Medical.

Health and Human Services employees were told in March to remove nicknames from email systems and signatures to comply with Trump order on gender.

For executives racing to lead in healthcare AI, I see the European Union, the United States and China as the leading ...

Gen Alpha (children 14 and younger) led the rise of GLP-1 utilization from 2023 to 2024, with an 85% growth rate in that period. But what is behind the sharp increase? 3 factors at play There are ...

Q1 2025 Earnings Call Transcript April 29, 2025 Altria Group, Inc. beats earnings expectations. Reported EPS is $1.23, ...

In a significant move, the NIH said it would reduce its reliance on animals in federally funded research and instead prioritize human-based alternatives.

As pressure grows to get artificial colors out of the U.S. food supply, the shift may well start at Abby Tampow’s laboratory ...

The market for obesity drugs presents one of the most lucrative targets for biopharmaceutical companies. Eli Lilly and Novo Nordisk are already raking in billions of dollars in sales with their weight ...